0000000001314972

AUTHOR

Rosa Dolz-marco

showing 27 related works from this author

Crystalline subtype of pre-descemetic corneal dystrophy.

2014

Purpose: To report corneal findings in a familial case of the crystalline subtype of pre- Descemetic corneal dystrophy. Case Report: A 19-year-old girl and her 44-year-old mother were found to have asymptomatic, bilateral, punctiform and multi-colored crystalline opacities across the whole posterior layer of the corneas. Endothelial specular microscopy revealed the presence of white round flecks located at different levels anterior to the endothelium. No systemic abnormalities or medications could be related to account for these findings. Conclusion: To the best of our knowledge, this is the third familial report of this rare corneal disorder. Differential diagnosis may include Schnyder cor…

Crystalline Subtype Pre-Descemetic Corneal Dystrophylcsh:Ophthalmologygenetic structureslcsh:RE1-994Crystalline Corneal Deposition Specular MicroscopyCase ReportCrystalline Subtype Pre-Descemetic Corneal Dystrophy; Crystalline Corneal Deposition Specular Microscopysense organseye diseases
researchProduct

Macular laser photocoagulation guided by spectral-domain optical coherence tomography versus fluorescein angiography for diabetic macular edema.

2011

Roberto Gallego-Pinazo1,2, Ana Marina Suelves-Cogollos1, Rosa Dolz-Marco1, J Fernando Arevalo3, Salvador García-Delpech1, J Luis Mullor4, Manuel Díaz-Llopis1,2,51Department of Ophthalmology, Hospital Universitario La Fe, Valencia, Spain; 2Centro de Investigación Biomédica en Red de Enfermedades Raras, Valencia, Spain; 3Retina and Vitreous Service, Clinical Ophthalmology Center, Caracas, Venezuela; 4Unit of Experimental Ophthalmology, Hospital Universitario La Fe, Valencia, Spain; 5University of Valencia, Faculty of Medicine, Valencia, SpainBackground: The aim of this study was to compare the efficacy of spectral-domain optical coherence tomography…

medicine.medical_specialtygenetic structuresmedicine.diagnostic_testbusiness.industryDiabetic macular edemaClinical OphthalmologySpectral domainFluorescein angiographyLasereye diseaseslaw.inventionOphthalmologyOptical coherence tomographymacular laser photocoagulationlawspectral-domain optical coherence tomographyfluorescein angiographyOphthalmologymedicinesense organsdiabetic macular edemabusinessOriginal Research
researchProduct

Need to consensus for novel findings by optical coherence tomography in patients with age-related macular degeneration

2012

medicine.medical_specialtyConsensusmedicine.diagnostic_testbusiness.industryGeneral MedicineMacular degenerationmedicine.diseaseRetinaMacular DegenerationOphthalmologyOptical coherence tomographyTerminology as TopicOphthalmologyAge relatedmedicineHumansIn patientbusinessTomography Optical CoherenceActa Ophthalmologica
researchProduct

Oral propranolol and intravitreal ranibizumab for refractory serous macular detachment secondary to retinal capillary hemangioblastoma

2015

medicine.medical_specialtyRetinal Neoplasmbusiness.industrymedicine.medical_treatmentRetinal detachmentGeneral MedicinePropranololmedicine.diseaseRefractoryOphthalmologyHemangioblastomaMedicineCombined Modality TherapyRanibizumabbusinessLaser coagulationmedicine.drugArchivos de la Sociedad Española de Oftalmología (English Edition)
researchProduct

Rituximab in refractory Vogt-Koyanagi-Harada disease.

2011

Introduction Vogt–Koyanagi–Harada (VKH) prognosis depends on early recognition and treatment; chronic disease may be developed when either delayed or inadequate treatment is performed, whereas other cases despite correct treatment are refractory to different drugs and also become chronic. We report a case of refractory VKH controlled with rituximab treatment. Case report A 41-year-old female with painful visual loss and headache was examined. (VA 0.4 in RE and hand movements (HM) in LE). Retinal examination demonstrated multiple serous retinal detachments in both eyes. High-dose oral steroids were started, followed by progressive tapering of prednisone. New acute anterior and posterior rela…

Vogt–Koyanagi–Harada diseasePathologymedicine.medical_specialtybusiness.industryBrief ReportDiseaseImmunommodulatorsmedicine.diseaseDermatologyeye diseasesChronic VKHOphthalmologySerous fluidInfectious DiseasesRefractoryPrednisonemedicineAdalimumabRituximabmedicine.symptombusinessRituximabTinnitusmedicine.drugJournal of ophthalmic inflammation and infection
researchProduct

Local safety of repeated intravitreal Ozurdex

2013

Sir, The article entitled ‘Twelve-month experience with Ozurdex for the treatment of macular edema associated with retinal vein occlusion'1 highlights the significant cataract progression in eyes receiving more than one Ozurdex implant. We retrospectively reviewed the charts of all patients with macular edema secondary to retinal vein occlusion (RVO) refractory to current therapies and treated with Ozurdex from April 2010 until March 2012. The mean age of patients with branch RVO (n=33) was 72.4. In eyes receiving a second Ozurdex implant, four out of the five phakic eyes showed progression of cataract requiring surgery. We registered one case of anterior chamber migration resulting in a bu…

Malemedicine.medical_specialtyRetinal Veingenetic structuresDexamethasoneMacular EdemaRefractoryOphthalmologyCorrespondenceRetinal Vein OcclusionOcclusionmedicineHumansIn patientGlucocorticoidsMacular edemaDexamethasonebusiness.industryIncidence (epidemiology)medicine.diseaseeye diseasesSurgeryOphthalmologyFemalesense organsImplantbusinessmedicine.drugEye
researchProduct

Safety and Efficacy of Ranibizumab in Macular Edema following Retinal Vein Occlusion.

2013

Macular edema is the leading cause of visual impairment in patients with retinal vein occlusion. Limited improvements may be obtained with laser photocoagulation or intravitreal triamcinolone. However, according to the data provided by randomized clinical trials, intravitreal injections of ranibizumab (Lucentis; Genentech, South San Francisco, CA) constitute a new effective and safe option for the management of these vision-threatening diseases. The aim of the present review is to summarize the clinical evidence of ranibizumab for macular edema due to retinal vein occlusions.

medicine.medical_specialtyRetinal Veingenetic structuresReviewlaw.inventionRandomized controlled triallcsh:OphthalmologylawOphthalmologyOcclusionMedicineIn patientranibizumabMacular edemaIntravitreal triamcinolonemacular edemabusiness.industrymedicine.diseaseVEGFeye diseasesantiangiogenic therapylcsh:RE1-994retinal vein occlusionRetinal vein occlusionsRanibizumabbusinessBiomedical engineeringmedicine.drugOphthalmology and eye diseases
researchProduct

Serous Macular Detachment Associated with Dome-Shaped Macula and Tilted Disc

2011

Introduction: An entirely new type of staphyloma has been recently described as dome-shaped macula (DSM). It is characterized by an abnormal convex macular contour within the concavity of a posterior staphyloma. We found DSM associated with serous macular detachment (SMD) and tilted disc in two consecutive cases. Case Reports: Case 1: A 37-year-old female presented to our department because of sudden onset blurred vision in her right eye (OD). The best-corrected visual acuity (BCVA) was 0.5 in both eyes. Funduscopy evidenced bilateral tilted disc associated with posterior staphyloma. Optical coherence tomography (OCT) demonstrated a DSM with SMD in her OD. After 15 months of follow-up, BCVA…

medicine.medical_specialtySerous macular detachmentVisual acuitygenetic structuresDome-shaped maculaOpticslcsh:OphthalmologyOptical coherence tomographyBlurred visionOphthalmologymedicineTilted discmedicine.diagnostic_testbusiness.industrySerous macular detachmentStaphylomaPublished: March 2011Posterior staphylomamedicine.diseaseeye diseasesOphthalmologyLeft eyelcsh:RE1-994Posterior staphylomasense organsmedicine.symptombusinessSudden onsetCase Reports in Ophthalmology
researchProduct

Prophylaxis of Pseudophakic Cystoid Macular Edema with Intraoperative Pegaptanib

2011

The purpose of this study was to determine the efficacy of an intraoperative intravitreal pegaptanib injection during phacoemulsification in preventing the development of pseudophakic cystoid macular edema (CME) following cataract surgery.This prospective, controlled pilot study was carried out at the Department of Ophthalmology, Nuevo Hospital Universitario y Politécnico La Fe, Valencia (Spain). Five hundred patients with cataract and healthy retina were included in the study. Patients were assigned in a 1:1 ratio to receive an intraoperative intravitreal pegaptanib injection (n=250) or not (control group, n=250) associated with standardized phacoemulsification surgery and postoperative tr…

Malemedicine.medical_specialtyPseudophakiagenetic structuresPegaptanibmedicine.medical_treatmentPilot ProjectsMacular EdemaHospitals UniversityPostoperative treatmentOphthalmologymedicineHumansPharmacology (medical)Prospective StudiesMacular edemaAgedAged 80 and overPharmacologyPhacoemulsificationSurgical complicationbusiness.industryIncidence (epidemiology)Outcome measuresPhacoemulsificationAptamers NucleotideCataract surgerymedicine.diseaseeye diseasesSurgeryOphthalmologyTreatment OutcomeSpainIntravitreal InjectionsFemalesense organsbusinessTomography Optical CoherenceFollow-Up Studiesmedicine.drugJournal of Ocular Pharmacology and Therapeutics
researchProduct

Oxidative stress and its downstream signaling in aging eyes

2014

María Dolores Pinazo-Durán,1,* Roberto Gallego-Pinazo,2,* Jose Javier García-Medina,1,3,* Vicente Zanón-Moreno,1,4 Carlo Nucci,5 Rosa Dolz-Marco,2 Sebastián Martínez-Castillo,2 Carmen Galbis-Estrada,1 Carla Marco-Ramírez,1 Maria Isabel López-Gálvez,6,* David J Galarreta,6,* Manuel Díaz-Llópis4,*1Ophthalmic Research Unit "Santiago Grisolía", Valencia, Spain; 2Department of Ophthalmology, Macula Section, The University and Polytechnic Hospital La Fe, Valencia, Spain; 3Department of Ophthalmology, University Hospital Reina Sofia, Murcia, Spain; 4Faculty of Medicine, University of Valencia, Spain; 5Uni…

GerontologyAginggenetic structuresGlaucomaDry Eye SyndromesReviewBioinformaticsmedicine.disease_causeEyeRetinal Diseasesophthalmic diseases; antioxidants; epidemiology; oxidative stress; eyes; agingMedicineHumansOcular Physiological PhenomenaPathologicalOcular Physiological PhenomenaAgedMechanism (biology)business.industrySettore MED/30 - Malattie Apparato VisivoRC952-954.6Glaucomaophthalmic diseasesGeneral MedicineDiabetic retinopathyeyesMacular degenerationmedicine.diseaseeye diseasesOxidative stress. Eyes. Aging. Ophthalmic Diseases. Antioxidants. Epidemiology.Oxidative StressantioxidantsGeriatricsDietary SupplementsDry Eye Syndromesepidemiologysense organsGeriatrics and GerontologybusinessOxidative stress
researchProduct

Use in clinical practice of an automated screening method of diabetic retinopathy that can be derived using a diagnostic artificial intelligence syst…

2021

Resumen Antecedentes y objetivo Comparar el rendimiento diagnostico de un sistema de inteligencia artificial (IA) de diagnostico autonomo para el diagnostico de retinopatia diabetica derivable (RDR) con la clasificacion manual. Materiales y metodos Sujetos con diabetes tipo 1 y 2 participaron en un programa de cribado de retinopatia diabetica (RD) entre 2011-2012. Se recogieron dos imagenes de cada ojo. Se obtuvieron imagenes retinianas no identificables, una centrada en el disco y otra en la fovea. Los examenes se clasificaron con el sistema de IA autonomo y manualmente por parte de oftalmologos anonimos. Los resultados del sistema de IA y de la clasificacion manual se compararon en cuanto…

Ophthalmology
researchProduct

Enhanced Oxidative Stress and Other Potential Biomarkers for Retinopathy in Type 2 Diabetics: Beneficial Effects of the Nutraceutic Supplements

2015

We have studied the global risk of retinopathy in a Mediterranean population of type 2 diabetes mellitus (T2DM) patients, according to clinical, biochemical, and lifestyle biomarkers. The effects of the oral supplementation containing antioxidants/omega 3 fatty acids (A/ω3) were also evaluated. Suitable participants were distributed into two main groups: (1) T2DMG (with retinopathy (+DR) or without retinopathy (−DR)) and (2) controls (CG). Participants were randomly assigned (+A/ω3) or not (−A/ω3) to the oral supplementation with a daily pill of Nutrof Omega (R) for 18 months. Data collected including demographics, anthropometrics, characteristics/lifestyle, ophthalmic examination (best cor…

Blood GlucoseMaleoptical coherenceGlycated Hemoglobin Alcsh:MedicineType 2 diabetesmedicine.disease_causeGastroenterologyAntioxidantschemistry.chemical_compoundMalondialdehyde80 and overglycosylatedAged 80 and overeducation.field_of_studyGeneral MedicineDiabetic retinopathyMiddle AgedMalondialdehydetype 2diabetes mellitusFemaleomega-3Tomography Optical CoherenceResearch ArticleRetinopathyAdultmedicine.medical_specialtyArticle Subjecthemoglobin APopulationtomographyfatty acidsGeneral Biochemistry Genetics and Molecular BiologyInternal medicineFatty Acids Omega-3medicineHumanseducationTriglyceridesAgedGlycated HemoglobinDiabetic RetinopathyGeneral Immunology and MicrobiologySettore MED/30 - Malattie Apparato Visivobusiness.industryadult; aged; aged 80 and over; antioxidants; biomarkers; blood glucose; diabetes mellitus type 2; diabetic retinopathy; fatty acids omega-3; female; hemoglobin A glycosylated; humans; male; malondialdehyde; middle aged; oxidative stress; tomography optical coherence; triglycerides; dietary supplementslcsh:RType 2 Diabetes Mellitusmedicine.diseaseOxidative StressEndocrinologyDiabetes Mellitus Type 2chemistryDietary SupplementsHemoglobinbusinessBiomarkersOxidative stressBioMed Research International
researchProduct

Update on intravitreal anti-tumor necrosis factor alpha therapies for ocular disorders

2014

Abstract Tumor necrosis factor alpha (TNF-?) is an important pro-inflammatory cytokine associated with a variety of ocular diseases. The currently available TNF-? inhibitors are etanercept, infliximab, adalimumab, golimumab, and certolizumab. Experimental and clinical studies on the intravitreal use of these agents have been reported with etanercept, infliximab, and adalimumab: etanercept has shown limited efficacy in scarce reports; infliximab has been associated with local safety concerns but appears to benefit certain cases; adalimumab has shown no efficacy in cases of age-related macular degeneration (AMD) or diabetic macular edema (DME), but the combination with bevacizumab may be effe…

musculoskeletal diseasesOncologymedicine.medical_specialtyPathologygenetic structuresBevacizumabReviewCertolizumabEtanerceptEtanerceptIntravitreal injectionInternal medicineOcular disordersmedicineAdalimumabskin and connective tissue diseasesTumor necrosis factor alphabusiness.industryAdalimumabMacular degenerationmedicine.diseaseInfliximabeye diseasesGolimumabInfliximabOphthalmologyInfectious DiseasesTumor necrosis factor alphasense organsbusinessmedicine.drugJournal of Ophthalmic Inflammation and Infection
researchProduct

Pattern Dystrophy of the Macula in a Case of Steinert Disease

2013

<b><i>Introduction:</i></b> Myotonic dystrophies are typically associated with ocular complications like ptosis, weakness of the ocular muscle and cataracts, but also with less recognized retinal changes. <b><i>Case Report:</i></b> A 41-year-old female with type 1 myotonic dystrophy complained of progressive vision loss. Slit lamp examination revealed the presence of typical bilateral polychromatic cataract with posterior subcapsular component. Dilated fundus examination was remarkable for bilateral macular depigmented changes. Multimodal imaging analysis of the macula suggested the presence of a butterfly-shaped pattern dystrophy. <b>&l…

Weaknessmedicine.medical_specialtygenetic structuresPattern dystrophyMyotonic dystrophyMyotonic dystrophychemistry.chemical_compoundPtosisCataractslcsh:OphthalmologySteinert diseaseOphthalmologyMaculopathyMedicinePublished online: September 2013business.industryRetinalmedicine.diseaseDilated fundus examinationPattern dystrophyeye diseasesSurgeryOphthalmologyAcquired vitelliform depositchemistrylcsh:RE1-994Maculopathysense organsmedicine.symptombusinessCase Reports in Ophthalmology
researchProduct

Outcomes of cataract surgery in diabetic patients: results of the Pan American Collaborative Retina Study Group.

2014

Purpose: This study was designed to evaluate the visual and anatomical outcomes after cataract surgery in diabetic patients with different intraoperative therapeutic strategies. Methods: The research design comprised of a multicentric, retrospective, interventional study conducted at 6 centers in Argentina, Brazil, Costa Rica, Puerto Rico, Spain, and Venezuela. We included 138 diabetic patients with at least 6-month follow-up following phacoemulsification and intraocular lens implantation. Best-corrected visual acuity (BCVA) and central subfield thickness were collected at baseline and at 1-, 2-, 3-, and 6-month follow-up. Of these, 42 cases were not treated with any intraoperative coadjuva…

MaleVascular Endothelial Growth Factor ATriamcinolone acetonideVisual acuitygenetic structuresmedicine.medical_treatmentExtração de catarataVisual AcuityIntraocular lensCuidados intraoperatóriosAngiogenesis InhibitorsTriamcinolonelcsh:OphthalmologyLens Implantation IntraocularDiabetic retinopathyAntibodies monoclonalAged 80 and overGeneral MedicineDiabetic retinopathyMiddle AgedMulticenter studyBevacizumabTreatment OutcomeCataract extractionChemotherapy AdjuvantEstudo multicêntricoIntravitreal InjectionsFemalemedicine.symptommedicine.drugAdultmedicine.medical_specialtyBevacizumabAntibodies Monoclonal HumanizedCataractMacular EdemaIntraoperative careOphthalmologyEdema macularmedicineAnticorpos monoclonaisHumansMacular edemaGlucocorticoidsAgedRetrospective StudiesMacular edemaDiabetic RetinopathyIntraoperative CarePhacoemulsificationbusiness.industryRetinopatia diabéticaPhacoemulsificationCataract surgeryFacoemulsificaçãomedicine.diseaseSurgeryImplante de lente intraocularOphthalmologyLens implantation intraocularlcsh:RE1-994businessFollow-Up StudiesArquivos brasileiros de oftalmologia
researchProduct

Intravitreal Docosahexaenoic Acid in a Rabbit Model: Preclinical Safety Assessment

2014

PurposeThe purpose of the present study was to evaluate the retinal toxicity of a single dose of intravitreal docosahexaenoic acid (DHA) in rabbit eyes over a short-term period.MethodsSixteen New Zealand albino rabbits were selected for this pre-clinical study. Six concentrations of DHA (Brudy Laboratories, Barcelona, Spain) were prepared: 10 mg/50 µl, 5 mg/50 µl, 2'5 mg/50 µl, 50 µg/50 µl, 25 µg/50 µl, and 5 µg/50 µl. Each concentration was injected intravitreally in the right eye of two rabbits. As a control, the vehicle solution was injected in one eye of four animals. Retinal safety was studied by slit-lamp examination, and electroretinography. All the rabbits were euthanized one week a…

MaleRetinal degenerationgenetic structuresÀcids grassosPharmacologyBiochemistryMicechemistry.chemical_compoundCorneaMedicine and Health SciencesRatolinsExperimentació animalDegeneració (Patologia)Multidisciplinarymedicine.diagnostic_testQFatty AcidsChromatographic TechniquesRDegeneration (Pathology)Animal ModelsLipidsChemistrymedicine.anatomical_structureNeurologyDocosahexaenoic acidPhysical SciencesMedicineRetinal DisordersRabbitsSafetyAnatomyResearch Articlemedicine.medical_specialtyHistologyDrug Research and DevelopmentDocosahexaenoic AcidsNew Zealand AlbinoScienceOcular AnatomyResearch and Analysis MethodsRetinaInjectionsAqueous HumorModel OrganismsOcular SystemElectroretinographyToxicity Tests AcutemedicineAnimalsFatty acidsGas ChromatographyPharmacologyDose-Response Relationship Drugbusiness.industrySignificant differenceBiology and Life SciencesRetinalmedicine.diseaseSurgeryVitreous BodyOphthalmologychemistryNeuro-OphthalmologyAnimal experimentationRabbit modelClinical MedicinebusinessElectroretinographyPLoS ONE
researchProduct

<p>A randomized multicenter study comparing seawater washes and carmellose artificial tears eyedrops in the treatment of dry eye syndrome</p…

2019

Purpose To investigate the safety and efficacy of sterile isotonic seawater washes vs standard treatment with carmellose artificial tears in dry eye syndrome (DES). Patients and methods This is a randomized multicenter prospective study with 12 weeks of follow-up. A group of patients with DES (N=60) were treated with seawater spray (Quinton®) five times daily, and another similar group (N=60) were treated with carmellose artificial tears eyedrops (Viscofresh® 0.5%) five times a day. The parameters studied and measured were as follows: Ocular Surface Disease Index questionnaire score, Schirmer I test (without anesthesia) score, tear osmolarity (TearLab®), tear breakup time, tear meniscus hei…

medicine.medical_specialtyCorneal stainingbusiness.industryStandard treatmentmedicine.medical_treatmenteye diseases03 medical and health sciencesOphthalmologyArtificial tears0302 clinical medicineMulticenter studyOphthalmology030221 ophthalmology & optometrymedicineTearsSeawaterOcular Surface Disease Indexsense organsbusinessProspective cohort study030217 neurology & neurosurgeryClinical Ophthalmology
researchProduct

Automated macular choroidal thickness measurement by swept-source optical coherence tomography in pseudoxanthoma elasticum

2016

Introduction Pseudoxanthoma elasticum (PXE) typically involves elastic fibers in blood vessels and Bruch membrane. Our purpose was to analyze retinal and choroidal macular thickness in patients with angioid streaks due PXE compared with a control group. Methods Best-corrected visual acuity (BCVA), axial length (AL), and macular swept-source optical coherence tomography were obtained. Automated segmentations of the retina and the choroid were used to obtain the corresponding thickness values. An age, gender and AL matched control group was used to compare the thickness values. Results Twelve eyes of 6 patients were included. The mean BCVA was 0.68 ± 0.29 versus 1.0 in controls (p < 0.001). T…

medicine.medical_specialtyVisual acuitygenetic structures03 medical and health scienceschemistry.chemical_compound0302 clinical medicineOptical coherence tomographyOphthalmologymedicineNeovascularizationRetinamedicine.diagnostic_testChoroidbusiness.industryRetinalPseudoxanthoma elasticummedicine.diseaseeye diseasesPXEAutomated segmentationOphthalmologyAngioid streaksChoroidal neovascularizationmedicine.anatomical_structurechemistry030221 ophthalmology & optometryOriginal Articlesense organsChoroidmedicine.symptombusiness030217 neurology & neurosurgeryInternational Journal of Retina and Vitreous
researchProduct

Use in clinical practice of an automated screening method of diabetic retinopathy that can be derived using a diagnostic artificial intelligence syst…

2020

Abstract Background and Objective To compare the diagnostic performance of an autonomous diagnostic artificial intelligence (AI) system for the diagnosis of derivable diabetic retinopathy (RDR) with manual classification. Materials and Methods Patients with type 1 and type 2 diabetes participated in a diabetic retinopathy (RD) screening program between 2011–2012. 2 images of each eye were collected. Unidentifiable retinal images were obtained, one centered on the disc and one on the fovea. The exams were classified with th e autonomous AI system and manually by anonymous ophthalmologists. The results of the AI system and manual classification were compared in terms of sensitivity and specif…

medicine.medical_specialtybusiness.industry030209 endocrinology & metabolismGeneral MedicinePrimary careDiabetic retinopathyType 2 diabetesmedicine.diseaseDecreased visionClinical Practice03 medical and health sciences0302 clinical medicineInternal medicineDiabetes mellitus030221 ophthalmology & optometryScreening methodmedicinebusinessMacular edemaArchivos de la Sociedad Española de Oftalmología (English Edition)
researchProduct

Update on the principles and novel local and systemic therapies for the treatment of non-infectious uveitis.

2012

Ocular inflammatory disorders constitute a sight-threatening group of diseases that might be managed according to their severity. Their treatment guidelines experience constant changes with new agents that improve the results obtained with former drugs. Nowadays we can make use of a five step protocol in which topical, periocular and systemic corticosteroids remain as the main therapy for non-infectious uveitis. In addition, immunosuppresive drugs can be added in order to enhance the anti-inflammatory effects and to play the role of corticosteroid-sparing agents. These can be organized in four other steps: cyclosporine and methotrexate in a second one; azathioprine, mycophenolate and tacrol…

medicine.medical_specialtyTreatment protocolCyclophosphamideAdministration TopicalImmunologyAnti-Inflammatory AgentsAzathioprineUveitisInfectious uveitisAdrenal Cortex HormonesmedicineImmunology and AllergyAnimalsHumansIntensive care medicinePharmacologyChlorambucilbusiness.industryTumor Necrosis Factor-alphaGeneral Medicinemedicine.diseaseTacrolimusSurgeryInjections IntravenousPractice Guidelines as TopicMethotrexateImmunotherapybusinessUveitisAlgorithmsImmunosuppressive Agentsmedicine.drugInflammationallergy drug targets
researchProduct

Noninfectious uveitis: strategies to optimize treatment compliance and adherence.

2015

Noninfectious uveitis includes a heterogenous group of sight-threatening ocular and systemic disorders. Significant progress has been made in the treatment of noninfectious uveitis in recent years, particularly with regard to the effective use of corticosteroids and non-corticosteroid immunosuppressive drugs, including biologic agents. All of these therapeutic approaches are limited, however, by any given patient's ability to comply with and adhere to their prescribed treatment. In fact, compliance and adherence are among the most important patient-related determinants of treatment success. We discuss strategies to optimize compliance and adherence.

Immunosuppressive treatmentmedicine.medical_specialtynoninfectious uveitisbusiness.industryintraocular inflammationimmunosuppressive treatmentReviewcomplianceBiologic AgentsIntraocular inflammationOphthalmologyInfectious uveitisTreatment successTreatment complianceOphthalmologymedicinetherapeutic failureTherapeutic failureadherenceIntensive care medicinebusinessClinical ophthalmology (Auckland, N.Z.)
researchProduct

Smoking and age-related macular degeneration: review and update.

2013

Age-related macular degeneration (AMD) is one of the main socioeconomical health issues worldwide. AMD has a multifactorial etiology with a variety of risk factors. Smoking is the most important modifiable risk factor for AMD development and progression. The present review summarizes the epidemiological studies evaluating the association between smoking and AMD, the mechanisms through which smoking induces damage to the chorioretinal tissues, and the relevance of advising patients to quit smoking for their visual health.

medicine.medical_specialtygenetic structuresbusiness.industryMacular degenerationSmokingReview ArticleMacular degenerationmedicine.diseaseQuit smokingeye diseasesOphthalmologylcsh:Ophthalmologylcsh:RE1-994OphthalmologyInternal medicineAge relatedEpidemiologymedicineEtiologyRisk factorsense organsRisk factorbusiness
researchProduct

Propranolol e inyecciones intravítreas de ranibizumab en el desprendimiento seroso macular secundario a hemangioblastoma retiniano capilar

2015

Ophthalmologybusiness.industryMedicinebusinessArchivos de la Sociedad Española de Oftalmología
researchProduct

Validation of Automated Screening for Referable Diabetic Retinopathy With an Autonomous Diagnostic Artificial Intelligence System in a Spanish Popula…

2020

Purpose: The purpose of this study is to compare the diagnostic performance of an autonomous artificial intelligence (AI) system for the diagnosis of referable diabetic retinopathy (RDR) to manual grading by Spanish ophthalmologists. Methods: Subjects with type 1 and 2 diabetes participated in a diabetic retinopathy (DR) screening program in 2011 to 2012 in Valencia (Spain), and two images per eye were collected according to their standard protocol. Mydriatic drops were used in all patients. Retinal images—one disc and one fovea centered—were obtained under the Medical Research Ethics Committee approval and de-identified. Exams were graded by the autonomous AI system (IDx-DR, Coralville, Io…

Pediatricsmedicine.medical_specialtyArtificial Intelligence SystemEndocrinology Diabetes and MetabolismBiomedical Engineering030209 endocrinology & metabolismBioengineeringRetina03 medical and health sciences0302 clinical medicinediabetic retinopathy screeningDiabetes MellitusInternal MedicinemedicineHumansMass ScreeningPrimary Health Carebusiness.industryDiabetic retinopathy screeningOriginal ArticlesDiabetic retinopathymedicine.diseaseartificial intelligenceSpanish populationdiabetic retinopathypopulation screening030221 ophthalmology & optometryPopulation screeningbusinessJournal of diabetes science and technology (Online)
researchProduct

Adult Coats’ Disease Successfully Managed with the Dexamethasone Intravitreal Implant (Ozurdex®) Combined with Retinal Photocoagulation

2012

Purpose: To report a case of Coats’ disease managed with the dexamethasone intravitreal implant Ozurdex® (Allergan, Inc., Irvine, Calif., USA) combined with retinal photocoagulation. Methods: A 46-year-old female with 20/200 visual acuity was diagnosed with Coats’ disease with secondary retinal vasoproliferative tumor. An initial approach was performed with an intravitreal injection of the sustained-release dexamethasone implant Ozurdex. After reattachment of the retina, the telangiectatic vessels were treated with laser photocoagulation. Results: The patient’s visual acuity improved to 20/25 after the intravitreal Ozurdex. No further recurrences of exudation were evident through the 12-mon…

medicine.medical_specialtyRetinal vasoproliferative tumorVisual acuitychemistry.chemical_compoundRetinal telangiectasislcsh:OphthalmologyOphthalmologymedicineDexamethasone Intravitreal ImplantDexamethasone intravitreal implant (Ozurdex®)Coats' diseaseCoats’ diseaseDexamethasoneRetinabusiness.industryRetinalmedicine.diseaseSurgeryOphthalmologymedicine.anatomical_structurechemistrylcsh:RE1-994Published: March 2012Retinal TelangiectasisImplantmedicine.symptombusinessmedicine.drugCase Reports in Ophthalmology
researchProduct

Evaluación preclínica de la toxicidad retiniana en la administración intravítrea de ácido docosahexaenoico en modelo experimental de conejo

2013

Objetivo: Evaluar la toxicidad retiniana a corto plazo de la administración intravítrea de una dosis única de ácido docosahexaenoico (DHA) en un modelo experimental de conejo. Material y métodos: Dieciséis conejos albinos Nueva Zelanda fueron seleccionados para este estudio toxicológico preclínico. Se prepararon seis concentraciones de DHA (Brudy Laboratorios, Barcelona, España): 10mg/50μl, 5mg/50μl, 2'5mg/50μl, 50μg/50μl, 25μg/50μl, 5μg/50μl. Cada concentración fue inyectada por vía pars plana en inyección intravítrea en el ojo derecho de dos conejos. La solución vehículo se inyectó en el ojo derecho de cuatro animales que se consideraron el grupo control. Se evaluó la seguridad retiniana …

toxicidad retinianadha:CIENCIAS MÉDICAS::Cirugía::Cirugía ocular [UNESCO]ácidos grasosUNESCO::CIENCIAS MÉDICAS::Cirugía::Cirugía ocular
researchProduct

Outcomes of cataract surgery in diabetic patients: results of the Pan American Collaborative Retina Study Group

2018

Purpose: This study was designed to evaluate the visual and anatomical outcomes after cataract surgery in diabetic patients with different intraoperative therapeutic strategies. Methods: The research design comprised of a multicentric, retrospective, interventional study conducted at 6 centers in Argentina, Brazil, Costa Rica, Puerto Rico, Spain, and Venezuela. We included 138 diabetic patients with at least 6-month follow-up following phacoemulsification and intraocular lens implantation. Best-corrected visual acuity (BCVA) and central subfield thickness were collected at baseline and at 1-, 2-, 3-, and 6-month follow-up. Of these, 42 cases were not treated with any intraoperative coadjuva…

genetic structures
researchProduct